Literature DB >> 8618867

Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3.

J Li1, J Ma, H Potter.   

Abstract

The inheritance of much early-onset Alzheimer disease (AD) has been linked to a dominant-acting locus on chromosome 14. Recently, the gene likely responsible for this genetic linkage has been identified and termed AD3. Five mutations have been found in AD3 that segregate with the disease phenotype in seven AD families and are not present in unaffected individuals. Here we report the existence of a gene encoding a seven transmembrane domain protein very similar to that encoded by AD3 in structure and sequence. This gene is located on chromosome 1, is expressed in a variety of tissues, including brain, and is predicted to harbor mutations causing nonchromosome 14 familial AD. The presence of several S/TPXX DNA binding motifs in both the AD3 protein and the AD3-like protein /AD4 protein suggests a possible role in intracellular signaling and gene expression or in linking chromatin to the nuclear membrane. Ways in which mutations in either gene could lead to AD are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618867      PMCID: PMC40320          DOI: 10.1073/pnas.92.26.12180

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.

Authors:  R E Tanzi; G Vaula; D M Romano; M Mortilla; T L Huang; R G Tupler; W Wasco; B T Hyman; J L Haines; B J Jenkins
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 2.  Model systems for the study of seven-transmembrane-segment receptors.

Authors:  H G Dohlman; J Thorner; M G Caron; R J Lefkowitz
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

Review 3.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

Authors:  J M Rozemuller; J J Abbink; A M Kamp; F C Stam; C E Hack; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation.

Authors:  T Wisniewski; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

6.  Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.

Authors:  J M Rozemuller; F C Stam; P Eikelenboom
Journal:  Neurosci Lett       Date:  1990-10-30       Impact factor: 3.046

7.  Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

Authors:  T Wisniewski; B Frangione
Journal:  Neurosci Lett       Date:  1992-02-03       Impact factor: 3.046

8.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

Authors:  Y Namba; M Tomonaga; H Kawasaki; E Otomo; K Ikeda
Journal:  Brain Res       Date:  1991-02-08       Impact factor: 3.252

9.  Formation of beta-amyloid protein deposits in brains of transgenic mice.

Authors:  D Quon; Y Wang; R Catalano; J M Scardina; K Murakami; B Cordell
Journal:  Nature       Date:  1991-07-18       Impact factor: 49.962

10.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

View more
  10 in total

1.  Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice.

Authors:  James H Park; Gabriel A Widi; David A Gimbel; Noam Y Harel; Daniel H S Lee; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

Review 2.  Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease.

Authors:  Bruce A Yankner; Tao Lu
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

3.  Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

Authors:  J Busciglio; H Hartmann; A Lorenzo; C Wong; K Baumann; B Sommer; M Staufenbiel; B A Yankner
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

4.  Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations.

Authors:  W Song; P Nadeau; M Yuan; X Yang; J Shen; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

Review 5.  Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.

Authors:  Huntington Potter; Antoneta Granic; Julbert Caneus
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

6.  Sequence conservation between porcine and human LRRK2.

Authors:  Knud Larsen; Lone Bruhn Madsen
Journal:  Mol Biol Rep       Date:  2007-11-03       Impact factor: 2.316

7.  Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I).

Authors:  S Janicki; M J Monteiro
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

8.  Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Aβ toxicity mechanisms in a Drosophila model.

Authors:  Stanislav Ott; Nikolas Dziadulewicz; Damian C Crowther
Journal:  Dis Model Mech       Date:  2015-04-23       Impact factor: 5.758

9.  Biological function of Presenilin and its role in AD pathogenesis.

Authors:  Shuting Zhang; Mingming Zhang; Fang Cai; Weihong Song
Journal:  Transl Neurodegener       Date:  2013-07-17       Impact factor: 8.014

Review 10.  Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease.

Authors:  Xin Wang; Xuan Zhou; Gongying Li; Yun Zhang; Yili Wu; Weihong Song
Journal:  Front Mol Neurosci       Date:  2017-09-15       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.